Senseera
Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.
About
Technology stack
detected 2026-06-13No comments yet. Be the first to share your take.
What does Senseera do?
Senseera offers an AI-driven Chromatin Liquid Biopsy platform that maps gene expression from blood, providing cell-type and state insights for diagnostics and disease monitoring. Their patented technology captures active chromatin to generate high-resolution gene expression biomarkers, empowering drug development and enabling precise diagnosis and monitoring of conditions like liver disease. The platform serves the pharmaceutical industry by enhancing target selection, trial design, and understa…
How much funding has Senseera raised?
Senseera has raised a total of $7M in funding. The most recent round on record is Seed.
Where is Senseera headquartered?
Senseera is headquartered in San Diego, United States.
When was Senseera founded?
Senseera was founded in 2020.
What industry does Senseera operate in?
Senseera operates in Healthcare, Blood, Diagnostics, Cancer, Genomics, Computational Biology.
How many employees does Senseera have?
Senseera has approximately 20 people on record.